Home Cart Sign in  
Chemical Structure| 2442-10-6 Chemical Structure| 2442-10-6

Structure of 1-Octen-3-yl Acetate
CAS No.: 2442-10-6

Chemical Structure| 2442-10-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Peter, Niklas ; Lichter, Jutta ; Hagvall, Lina ; Bock, Udo ; Blomeke, Brunhilde ;

Abstract: Fragrances are important contact allergens; however, investigation of their skin sensitization potency has been challenging in new approach methods (NAMs). Many fragrance chems. are susceptible to autoxidation or can be metabolized by enzymes constitutively expressed in skin keratinocytes. Strong sensitizers can be formed in both of these processes. Further, keratinocytes can modulate the dendritic cell (DC) activation and maturation potential, a key event in the acquisition of contact allergy. To evaluate the 2D coculture model consisting of keratinocytes and DCs using different weak to moderate sensitizing fragrance chems. Further, to investigate fragrances and related oxidation products in the in vitro model and compare to in vivo data. Chems. were tested in the coculture activation test (COCAT), consisting of HaCaT keratinocytes and THP-1 cells. THP-1 cell surface expression of costimulatory and adhesion mols. (CD86 and CD54) collected after 24 h incubation with the chems. was analyzed using flow cytometry. Twenty-four mols. were tested pos., three were neg. (n = 27). Four pairs were evaluated, with aldehydes showing a 6- to 13-fold stronger responses compared to their corresponding alcs. Results provide insight into the activation of DC in their natural environment of keratinocytes. α,β-Unsaturated alcs. were classified as weaker sensitizers compared to their corresponding aldehydes. In sum, testing of fragrances retrieved results in good agreement with in vivo data.

Keywords: allergic contact dermatitis ; cosmetics ; fragrances

Purchased from AmBeed:

Alternative Products

Product Details of [ 2442-10-6 ]

CAS No. :2442-10-6
Formula : C10H18O2
M.W : 170.25
SMILES Code : CC(OC(CCCCC)C=C)=O
MDL No. :MFCD00036568
InChI Key :DOJDQRFOTHOBEK-UHFFFAOYSA-N
Pubchem ID :17121

Safety of [ 2442-10-6 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H227-H302-H317
Precautionary Statements:P210-P280

Computational Chemistry of [ 2442-10-6 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 0
Fraction Csp3 0.7
Num. rotatable bonds 7
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 50.99
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

26.3 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.58
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.13
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.68
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.47
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.6
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.69

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.41
Solubility 0.669 mg/ml ; 0.00393 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.35
Solubility 0.0758 mg/ml ; 0.000445 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.45
Solubility 0.601 mg/ml ; 0.00353 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.12 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.42
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 2442-10-6 ]

Alkenyls

Chemical Structure| 122763-67-1

A112335 [122763-67-1]

tert-Butyl 3-hydroxypent-4-enoate

Similarity: 0.75

Chemical Structure| 36840-85-4

A146184 [36840-85-4]

Pentane-1,5-diyl diacrylate

Similarity: 0.74

Chemical Structure| 4720-83-6

A173014 [4720-83-6]

6-Oxabicyclo[3.2.1]oct-3-en-7-one

Similarity: 0.71

Chemical Structure| 64630-63-3

A108658 [64630-63-3]

7-Oxabicyclo[4.1.0]heptan-3-ylmethyl acrylate

Similarity: 0.69

Chemical Structure| 2497-18-9

A181037 [2497-18-9]

trans-2-Hexenyl acetate

Similarity: 0.69

Aliphatic Chain Hydrocarbons

Chemical Structure| 122763-67-1

A112335 [122763-67-1]

tert-Butyl 3-hydroxypent-4-enoate

Similarity: 0.75

Chemical Structure| 36840-85-4

A146184 [36840-85-4]

Pentane-1,5-diyl diacrylate

Similarity: 0.74

Chemical Structure| 638-59-5

A140335 [638-59-5]

Tetradecyl acetate

Similarity: 0.69

Chemical Structure| 10233-13-3

A111861 [10233-13-3]

Isopropyl dodecanoate

Similarity: 0.69

Chemical Structure| 2497-18-9

A181037 [2497-18-9]

trans-2-Hexenyl acetate

Similarity: 0.69

Esters

Chemical Structure| 122763-67-1

A112335 [122763-67-1]

tert-Butyl 3-hydroxypent-4-enoate

Similarity: 0.75

Chemical Structure| 4098-06-0

A113736 [4098-06-0]

(2R,3R,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate

Similarity: 0.74

Chemical Structure| 2873-29-2

A136632 [2873-29-2]

(2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate

Similarity: 0.74

Chemical Structure| 36840-85-4

A146184 [36840-85-4]

Pentane-1,5-diyl diacrylate

Similarity: 0.74

Chemical Structure| 4720-83-6

A173014 [4720-83-6]

6-Oxabicyclo[3.2.1]oct-3-en-7-one

Similarity: 0.71